Atorable C 20/75 Capsule contains Atorvastatin 20mg + Clopidogrel 75mg, a clinically validated combination for cardiovascular protection and lipid management. Atorvastatin reduces LDL cholesterol and triglycerides, while Clopidogrel provides antiplatelet action to prevent blood clots, reducing the risk of heart attacks and strokes.
This dual-action therapy is suitable for patients with high cardiovascular risk, including those with hyperlipidemia, coronary artery disease, or prior ischemic events. It simplifies treatment by combining two essential agents in one tablet, improving patient compliance and overall heart health.
For distributors and resellers, Atorable C 20/75 Tablet is a high-demand cardiology product, widely prescribed in cardiology OPDs, hospitals, and preventive care centers. Its consistent need ensures year-round movement and repeat orders.
Adding Atorable C 20/75 Capsule to your cardiology and antiplatelet portfolio strengthens your product range, opening opportunities for hospital supply, pharmacy distribution, institutional tenders, export channels, and third-party manufacturing. Its clinical importance makes it a profitable and strategic addition for pharmaceutical distributors.